xeloda for metastatic breast cancer

Release time ：Dec-21,2024

Xeloda is a frequently utilized medication for treating metastatic breast cancer, functioning by inhibiting the proliferation of cancer cells. As with many oncological drugs, Xeloda can also lead to a range of side effects. Initially, patients might encounter mild adverse reactions such as nausea, vomiting, and diarrhea, which are typically manageable through dietary adjustments and antiemetic medications. Subsequently, some individuals may develop hand-foot syndrome, manifesting as numbness, pain, or redness and swelling in the extremities. In such instances, physicians may recommend a reduction in dosage or a temporary halt to therapy. More severe adverse effects, such as liver damage, infections, and blood clots, necessitate prompt medical intervention. Throughout the course of Xeloda treatment, patients should vigilantly monitor their health and promptly consult a physician at the first sign of unusual symptoms. Additionally, adhering to the physician's advice and undergoing regular necessary examinations is crucial to ensure the safety and efficacy of the treatment. Remember, do not alter the medication dosage or discontinue the medication without guidance, as this could compromise therapeutic outcomes or introduce unnecessary risks.